Related references
Note: Only part of the references are listed.Testosterone gel improves appetite and reduces tiredness in males with advanced cancer
Thomas Zheng Jie Teng et al.
BMJ SUPPORTIVE & PALLIATIVE CARE (2021)
Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma
Geraldine Yanlei Lei et al.
VISCERAL MEDICINE (2021)
Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma
Yang Jun Kang et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2020)
Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients
Masaki Maeda et al.
LIVER CANCER (2020)
Trans-arterial chemoembolization plus radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis
Chuan Hao Gui et al.
EJSO (2020)
Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety
Zi-shu Zhang et al.
BMC CANCER (2019)
Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database
Johannes Uhlig et al.
EUROPEAN RADIOLOGY (2019)
Epidemiology and Management of Hepatocellular Carcinoma
Laura Kulik et al.
GASTROENTEROLOGY (2019)
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
Adam Doyle et al.
JOURNAL OF HEPATOLOGY (2019)
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma
Chia-Yang Hsu et al.
BMC CANCER (2018)
Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Yi-Sheng Liu et al.
BMC GASTROENTEROLOGY (2018)
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Giulio Marchesini et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
Elisabetta Degasperi et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Roman Kloeckner et al.
BMC CANCER (2015)
Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients
Lan Zhang et al.
MEDICAL ONCOLOGY (2015)
Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results
David P. Cosgrove et al.
RADIOLOGY (2015)
Surveillance for hepatocellular carcinoma
Morris Sherman
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Transarterial chemoembolization for hepatocellular carcinoma: A review of techniques
Norihiro Imai et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Rodolfo Sacco et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Principles of Cancer Screening: Lessons From History and Study Design Issues
Jennifer M. Croswell et al.
SEMINARS IN ONCOLOGY (2010)
Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma
Chung-Bao Hsieh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Share Paper
